|
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
|
journal
|
February 2007 |
|
Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics
|
journal
|
April 2004 |
|
Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
|
journal
|
September 2016 |
|
Outcome and prognostic markers in severe drug-induced liver disease
|
journal
|
January 2005 |
|
Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
|
journal
|
April 2014 |
|
The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients
|
journal
|
August 2004 |
|
Antiemetic research: future directions
|
journal
|
November 2010 |
|
Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice—a longitudinal analysis
|
journal
|
August 2014 |
|
ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
|
journal
|
October 2018 |
|
Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
|
journal
|
April 2013 |
|
Drug elimination in chronic liver diseases
|
journal
|
January 1997 |
|
Antecedent liver disease and drug toxicity
|
journal
|
December 1999 |
|
Morphologic Spectrum of Drug-Induced Hepatic Disease
|
journal
|
December 1995 |
|
Hepatotoxicity of Chemotherapeutic and Oncologic Agents
|
journal
|
December 1995 |
|
Guidance on the management of diarrhoea during cancer chemotherapy
|
journal
|
September 2014 |
|
Acute and long-term gastrointestinal consequences of chemotherapy
|
journal
|
February 2009 |
|
Targeted therapy-induced diarrhea: A review of the literature
|
journal
|
May 2014 |
|
Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis
|
journal
|
April 2013 |
|
Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases
|
journal
|
June 2008 |
|
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy
|
journal
|
December 2003 |
|
Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
|
journal
|
August 2005 |
|
Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases
|
journal
|
June 2005 |
|
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
|
journal
|
May 2017 |
|
Evaluation and Management of Treatment-Related Diarrhea in Patients with Advanced Cancer: A Review
|
journal
|
October 2008 |
|
Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study
|
journal
|
May 2014 |
|
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
|
journal
|
June 1998 |
|
Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency
|
journal
|
July 2013 |
|
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
|
journal
|
April 2014 |
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
|
journal
|
June 2015 |
|
Hepatotoxicity of Chemotherapy
|
journal
|
February 2006 |
|
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
|
journal
|
November 2001 |
|
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
|
journal
|
July 2016 |
|
Drug-Induced Hepatotoxicity
|
journal
|
July 2003 |
|
Chemotherapy-Induced Nausea and Vomiting
|
journal
|
June 2008 |
|
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
|
journal
|
April 2016 |
|
Uridine triacetate - an antidote in the treatment of 5-fluorouracil or capecitabine poisoning
|
journal
|
March 2019 |
|
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
|
journal
|
September 2016 |
|
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
|
journal
|
September 2016 |
|
The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting
|
journal
|
June 2017 |
|
Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines
|
journal
|
October 2018 |
|
Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications
|
journal
|
July 2014 |
|
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5‐fluorouracil: a meta‐analysis of published trials
|
journal
|
November 2014 |
|
Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications
|
journal
|
November 2015 |
|
Guidelines on the management of abnormal liver blood tests
|
journal
|
November 2017 |
|
Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines
|
journal
|
November 2015 |
|
Estimating the Cost of Illness in Colorectal Cancer Patients Who Were Hospitalized for Severe Chemotherapy-Induced Diarrhea
|
journal
|
January 2005 |
|
Chemotherapy induced diarrhea
|
journal
|
December 2007 |
|
Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
|
journal
|
December 2009 |
|
Population study of dihydropyrimidine dehydrogenase in cancer patients.
|
journal
|
November 1994 |
|
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
|
journal
|
January 1995 |
|
Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea
|
journal
|
July 2004 |
|
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
|
journal
|
May 2006 |
|
HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer
|
journal
|
February 2011 |
|
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
|
journal
|
October 2017 |
|
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
|
journal
|
March 2013 |
|
The Consequences of Diarrhea Occurring During Chemotherapy for Colorectal Cancer: A Retrospective Study
|
journal
|
June 2000 |
|
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
|
journal
|
November 2016 |
|
Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management
|
journal
|
January 2017 |
|
Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats
|
journal
|
December 2008 |
|
NCCN Guidelines Insights: Antiemesis, Version 2.2017
|
journal
|
July 2017 |